GSA Capital Partners’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,444
| Closed | -$349K | – | 1925 |
|
|
2025
Q4 | $349K | Sell |
2,444
-734
| -23% | -$98.3K | 0.03% | 1084 |
|
|
2025
Q3 | $381K | Buy |
+3,178
| New | +$403K | 0.03% | 1043 |
|
|
2025
Q2 | – | Sell |
-4,425
| Closed | -$614K | – | 1924 |
|
|
2025
Q1 | $614K | Buy |
+4,425
| New | +$687K | 0.06% | 653 |
|
|
2024
Q4 | – | Sell |
-7,808
| Closed | -$1.42M | – | 1787 |
|
|
2024
Q3 | $1.42M | Buy |
7,808
+5,200
| +199% | +$770K | 0.11% | 254 |
|
|
2024
Q2 | $310K | Buy |
+2,608
| New | +$274K | 0.02% | 1260 |
|
|
2024
Q1 | – | Sell |
-4,917
| Closed | -$490K | – | 1782 |
|
|
2023
Q4 | $490K | Buy |
+4,917
| New | +$481K | 0.04% | 811 |
|
|
2022
Q4 | – | Sell |
-3,625
| Closed | -$546K | – | 1649 |
|
|
2022
Q3 | $546K | Buy |
+3,625
| New | +$603K | 0.07% | 506 |
|
|
2021
Q3 | – | Sell |
-1,382
| Closed | -$284K | – | 1590 |
|
|
2021
Q2 | $284K | Buy |
+1,382
| New | +$284K | 0.03% | 983 |
|
|
2021
Q1 | – | Sell |
-1,743
| Closed | -$374K | – | 1272 |
|
|
2020
Q4 | $374K | Buy |
1,743
+248
| +17% | +$48.1K | 0.06% | 620 |
|
|
2020
Q3 | $273K | Buy |
+1,495
| New | +$281K | 0.05% | 811 |
|
|
2019
Q2 | – | Sell |
-3,600
| Closed | -$862K | – | 1567 |
|
|
2019
Q1 | $862K | Hold |
3,600
| – | – | 0.09% | 372 |
|
|
2018
Q4 | $827K | Sell |
3,600
-7,141
| -66% | -$1.76M | 0.1% | 304 |
|
|
2018
Q3 | $3.04M | Buy |
10,741
+4,032
| +60% | +$1.18M | 0.17% | 96 |
|
|
2018
Q2 | $1.97M | Buy |
+6,709
| New | +$1.83M | 0.1% | 287 |
|
|
2017
Q2 | – | Sell |
-4,438
| Closed | -$678K | – | 1795 |
|
|
2017
Q1 | $678K | Buy |
4,438
+1,959
| +79% | +$286K | 0.04% | 900 |
|
|
2016
Q4 | $365K | Sell |
2,479
-2,679
| -52% | -$388K | 0.02% | 1210 |
|
|
2016
Q3 | $652K | Sell |
5,158
-2,121
| -29% | -$256K | 0.04% | 894 |
|
|
2016
Q2 | $821K | Buy |
7,279
+4,824
| +196% | +$501K | 0.05% | 764 |
|
|
2016
Q1 | $256K | Sell |
2,455
-2,797
| -53% | -$267K | 0.02% | 1379 |
|
|
2015
Q4 | $592K | Sell |
5,252
-758
| -13% | -$83.8K | 0.03% | 1054 |
|
|
2015
Q3 | $658K | Sell |
6,010
-3,800
| -39% | -$406K | 0.03% | 946 |
|
|
2015
Q2 | $938K | Buy |
9,810
+1,200
| +14% | +$112K | 0.04% | 955 |
|
|
2015
Q1 | $802K | Buy |
8,610
+1,300
| +18% | +$114K | 0.03% | 1049 |
|
|
2014
Q4 | $599K | Buy |
+7,310
| New | +$560K | 0.04% | 803 |
|
|
2014
Q1 | – | Sell |
-4,120
| Closed | -$262K | – | 1664 |
|
|
2013
Q4 | $262K | Buy |
+4,120
| New | +$265K | 0.02% | 1303 |
|
Other funds holding ICUI
VPM
VCM
RRAM
GSA Capital Partners's ICUI Position: Q1 2026 in Review
GSA Capital Partners sold out of ICU Medical (ICUI) in Q1 2026, closing a stake of 2,444 shares — an estimated $349K sold.
GSA Capital Partners first reported a position in ICUI in Q4 2013 and held it in 25 quarters. The position peaked at $3.04M in Q3 2018. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.
- GSA Capital Partners reported no remaining ICU Medical position as of Q1 2026 after selling out during the quarter.
- GSA Capital Partners sold 2,444 ICU Medical shares in Q1 2026, an estimated $349K.
- GSA Capital Partners first reported a position in ICU Medical in Q4 2013 and held it in 25 quarters.
- GSA Capital Partners's ICU Medical position peaked at $3.04M in Q3 2018.
- 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.
Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.